These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9405054

  • 1. A novel assay for evaluating glycogenolysis in rat adipocytes and the inability of insulin to antagonize glycogenolysis in this cell type.
    Sekar N, Li J, bin He Z, Shechter Y.
    Biochemistry; 1997 Dec 23; 36(51):16206-11. PubMed ID: 9405054
    [Abstract] [Full Text] [Related]

  • 2. Antilipolytic actions of vanadate and insulin in rat adipocytes mediated by distinctly different mechanisms.
    Li J, Elberg G, Sekar N, bin He Z, Shechter Y.
    Endocrinology; 1997 Jun 23; 138(6):2274-9. PubMed ID: 9165011
    [Abstract] [Full Text] [Related]

  • 3. Calyculin and okadaic acid promote perilipin phosphorylation and increase lipolysis in primary rat adipocytes.
    He J, Jiang H, Tansey JT, Tang C, Pu S, Xu G.
    Biochim Biophys Acta; 2006 Feb 23; 1761(2):247-55. PubMed ID: 16545598
    [Abstract] [Full Text] [Related]

  • 4. Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes.
    Li J, Elberg G, Shechter Y.
    Biochim Biophys Acta; 1996 Jul 24; 1312(3):223-30. PubMed ID: 8703991
    [Abstract] [Full Text] [Related]

  • 5. Effect of okadaic acid in rat adipocytes: differential stimulation of glucose and lipid metabolism and induction of refractoriness to insulin and vanadate.
    Shisheva A, Shechter Y.
    Endocrinology; 1991 Nov 24; 129(5):2279-88. PubMed ID: 1657568
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
    Xue B, Greenberg AG, Kraemer FB, Zemel MB.
    FASEB J; 2001 Nov 24; 15(13):2527-9. PubMed ID: 11641262
    [Abstract] [Full Text] [Related]

  • 7. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW.
    Diabetologia; 1997 Oct 24; 40(10):1197-203. PubMed ID: 9349602
    [Abstract] [Full Text] [Related]

  • 8. Independent signal-transduction pathways for vanadate and for insulin in the activation of glycogen synthase and glycogenesis in rat adipocytes.
    Sekar N, Li J, He Z, Gefel D, Shechter Y.
    Endocrinology; 1999 Mar 24; 140(3):1125-31. PubMed ID: 10067835
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
    Resjö S, Oknianska A, Zolnierowicz S, Manganiello V, Degerman E.
    Biochem J; 1999 Aug 01; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
    [Abstract] [Full Text] [Related]

  • 10. Involvement of calyculin A inhibitable protein phosphatases in the cyclic AMP signal transduction pathway of mouse corticotroph tumour (AtT20) cells.
    Antaraki A, Ang KL, Antoni FA.
    Br J Pharmacol; 1997 Jul 01; 121(5):991-9. PubMed ID: 9222558
    [Abstract] [Full Text] [Related]

  • 11. Dual effects of pituitary adenylate cyclase-activating polypeptide and isoproterenol on lipid metabolism and signaling in primary rat adipocytes.
    Akesson L, Ahrén B, Manganiello VC, Holst LS, Edgren G, Degerman E.
    Endocrinology; 2003 Dec 01; 144(12):5293-9. PubMed ID: 12960103
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes.
    Castan I, Wijkander J, Manganiello V, Degerman E.
    Biochem J; 1999 Apr 15; 339 ( Pt 2)(Pt 2):281-9. PubMed ID: 10191258
    [Abstract] [Full Text] [Related]

  • 13. Acute effects of progesterone on glucose metabolism in rat adipocytes: are they modulated by endogenous adenosine?
    Sutter-Dub MT, Cordoba P.
    Metabolism; 1997 Jun 15; 46(6):595-604. PubMed ID: 9186292
    [Abstract] [Full Text] [Related]

  • 14. Desensitization of adenosine receptor-mediated inhibition of lipolysis. The mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes.
    Hoffman BB, Chang H, Dall'Aglio E, Reaven GM.
    J Clin Invest; 1986 Jul 15; 78(1):185-90. PubMed ID: 3013937
    [Abstract] [Full Text] [Related]

  • 15. Effects of thyroid hormone on regulation of lipolysis and adenosine 3',5'-monophosphate metabolism in 3T3-L1 adipocytes.
    Elks ML, Manganiello VC.
    Endocrinology; 1985 Sep 15; 117(3):947-53. PubMed ID: 2410243
    [Abstract] [Full Text] [Related]

  • 16. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML, Manganiello VC.
    Endocrinology; 1984 Oct 15; 115(4):1262-8. PubMed ID: 6207009
    [Abstract] [Full Text] [Related]

  • 17. Prostacyclin production by isolated rat adipocytes: evidence for cyclic adenosine 3',5'-monophosphate-dependent and independent mechanisms and for a selective effect of insulin.
    Axelrod L, Ryan CA, Shaw JL, Kieffer JD, Ausiello DA.
    Endocrinology; 1986 Nov 15; 119(5):2233-9. PubMed ID: 2429831
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of lipolysis by palmitate, H2O2 and the sulfonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets.
    Müller G, Wied S, Over S, Frick W.
    Biochemistry; 2008 Feb 05; 47(5):1259-73. PubMed ID: 18186616
    [Abstract] [Full Text] [Related]

  • 19. The antilipolytic action of insulin on adrenocorticotrophin-stimulated rat adipocytes. The roles of adenosine 3',5'-monophosphate and the protein kinase dependent on adenosine 3',5'-monophosphate.
    Wong EH, Loten EG.
    Eur J Biochem; 1981 Mar 16; 115(1):17-22. PubMed ID: 6262080
    [Abstract] [Full Text] [Related]

  • 20. A dynamic system for suppression and re-expression of insulin and pervanadate bioresponses in rat adipocytes. Treatment with okadaic acid and staurosporine.
    Shisheva A, Shechter Y.
    Biochem Pharmacol; 1994 Apr 29; 47(9):1537-44. PubMed ID: 8185665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.